Your browser does not fully support modern features. Please upgrade for a smoother experience.
Subject:
All Disciplines Arts & Humanities Biology & Life Sciences Business & Economics Chemistry & Materials Science Computer Science & Mathematics Engineering Environmental & Earth Sciences Medicine & Pharmacology Physical Sciences Public Health & Healthcare Social Sciences
Sort by:
Most Viewed Latest Alphabetical (A-Z) Alphabetical (Z-A)
Filter:
All Topic Review Biography Peer Reviewed Entry Video Entry
Topic Review
Monocytes’ and Macrophages’ Proinflammatory Immune Response
Monocytes and macrophages are a central component of the innate immune system and exert an important function in orchestrating inflammation.
  • 1.1K
  • 13 Jul 2022
Topic Review
Connections between COVID-19 and Autoimmune Diseases
Autoimmune diseases and SARS-CoV-2 infections are intertwined in several ways. Both conditions lead to immune-mediated tissue damage, the immune response is accompanied by the increased secretion of inflammatory cytokines and both conditions can be treated using immunomodulatory drugs. Patients with certain autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes, cardiac sarcoidosis, idiopathic pulmonary fibrosis, autoimmune hepatitis, multiple sclerosis and others, are more susceptible to SARS-CoV-2 infection, either because of the active autoimmune disease or because of the medications used to treat it. Conversely, SARS-CoV-2 infection can also cause certain autoimmune diseases. 
  • 1.1K
  • 25 Nov 2022
Topic Review
Protease Inhibitors as Antivirals
Viral proteases play a key role in viral replication for all positive single-stranded RNA viruses and some DNA viruses, such as herpesviruses. To treat infections caused by these viruses, proteases are considered excellent drug targets. Protease inhibitors are now routinely used in antiviral therapy for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections. Since SARS-CoV-2 Mpro plays a key role in viral replication by cleaving viral polyproteins, inhibition of its catalytic activity represents an attractive therapeutic approach for the treatment of COVID-19.
  • 1.1K
  • 08 Feb 2024
Topic Review
Antioxidant Effects of Lycopene
Malaria is a disease that affects thousands of people around the world every year. Its pathogenesis is associated with the production of reactive oxygen and nitrogen species (RONS) and lower levels of micronutrients and antioxidants. Patients under drug treatment have high levels of oxidative stress biomarkers in the body tissues, which limits the use of these drugs. Therefore, several studies have suggested that RONS inhibition may represent an adjuvant therapeutic strategy in the treatment of these patients by increasing the antioxidant capacity of the host. In this sense, supplementation with antioxidant compounds such as zinc, selenium, and vitamins A, C, and E has been suggested as part of the treatment. Among dietary antioxidants, lycopene is the most powerful antioxidant among the main carotenoids. 
  • 1.1K
  • 09 Jan 2023
Topic Review
Helicobacter Pylori Survival Tactics
Helicobacter pylori is well established as a causative agent for gastritis, peptic ulcer, and gastric cancer. Armed with various inimitable virulence factors, this Gram-negative bacterium is one of few microorganisms that is capable of circumventing the harsh environment of the stomach. The unique spiral structure, flagella, and outer membrane proteins accelerate H. pylori movement within the viscous gastric mucosal layers while facilitating its attachment to the epithelial cells. Furthermore, secretion of urease from H. pylori eases the acidic pH within the stomach, thus creating a niche for bacteria survival and replication. Upon gaining a foothold in the gastric epithelial lining, bacterial protein CagA is injected into host cells through a type IV secretion system (T4SS), which together with VacA, damage the gastric epithelial cells.
  • 1.1K
  • 29 Mar 2022
Topic Review
Genitourinary Tuberculosis
Genitourinary tuberculosis (GUTB) represents a disease often underestimated by urological specialists, particularly in settings such as the European one, where the pathology is less frequent. Similar to other uncommon diseases at these latitudes, GUTB is a neglected clinical problem. Its symptoms might be mistaken for other urological diseases, and therefore its diagnosis might be delayed.
  • 1.1K
  • 18 Nov 2021
Topic Review
Granulicatella spp.
Granulicatella spp. are non-motile, non-sporulating, facultatively anaerobic Gram-positive cocci. These organisms have been referred to by several names, such as “nutritionally deficient streptococci”, “vitamin-B dependent streptococci” and “pyridoxal-dependent streptococci”, because of their fastidious nutritional requirements, which can often make culture isolation challenging. Known to be a member of the normal microbiota of the human oral cavity and urogenital and intestinal tracts, similar to other streptococci, Granulicatella spp. can cause bacteremia, sepsis and infective endocarditis. Considering the difficulty in growing this organism on culture medium, the fact that it is now included among the bacteria known to be responsible for culture-negative infective endocarditis suggests that its pathogenic role could be highly underestimated. Moreover, being considered such a rare causative agent, it is not a target of standard antibiotic empiric treatment. 
  • 1.1K
  • 27 Dec 2022
Topic Review
Histoplasmosis in Solid Organ Transplantation
Histoplasma capsulatum, the etiological agent for histoplasmosis, is a dimorphic fungus that grows as a mold in the environment and as a yeast in human tissues. It has a broad global distribution with shifting epidemiology. While in immunocompetent individuals infection is usually self-resolving, solid organ transplant recipients are at increased risk of symptomatic disease with dissemination to extrapulmonary tissue. Diagnosis of histoplasmosis relies on direct observation of the pathogen (histopathology, cytopathology, and culture) or detection of antigens, antibodies, or nucleic acids. All transplant recipients with histoplasmosis warrant therapy, though the agent of choice and duration of therapy depends on the severity of disease.
  • 1.1K
  • 05 Mar 2024
Topic Review
Sepsis and HMGB1 Release
Sepsis remains a common cause of death in intensive care units, accounting for approximately 20% of total deaths worldwide. Its pathogenesis is partly attributable to dysregulated inflammatory responses to bacterial endotoxins (such as lipopolysaccharide, LPS), which stimulate innate immune cells to sequentially release early cytokines (such as tumor necrosis factor (TNF) and interferons (IFNs)) and late mediators (such as high-mobility group box 1, HMGB1).  Below is a brief summary of the intricate mechanisms underlying the regulation of bacterial endotoxin-induced HMGB1 release.
  • 1.1K
  • 13 Sep 2021
Topic Review
Sinks and Bacterial Healthcare-Associated Infections in ICU
Sink drains in hospitals have long been known to harbor an abundant microbiota comprising up to 103–105 CFU/mL Gram-negative rods, especially waterborne bacteria. intensive care unit (ICU) sink/sink drains can be contaminated by MDR bacteria originating from patients. These reservoirs can in turn be a source of contamination of other ICU patients. Studies have used molecular biology techniques to ascertain whether bacterial clones causing such heathcare-associated infections can indeed come from contaminated sinks.
  • 1.1K
  • 15 Jun 2022
Topic Review
SARS-CoV-2 Spread
SARS-CoV-2 spreads through close contact, causing the coronavirus disease 2019 (COVID-19); thus, emergency lockdowns have been implemented worldwide to avoid its spread. As of 27 March 2022, the β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 487 million individuals worldwide, causing more than 6.14 million deaths. SARS-CoV-2 spreads through close contact, causing the coronavirus disease 2019 (COVID-19); thus, emergency lockdowns have been implemented worldwide to avoid its spread. COVID-19 is not the first infectious disease that humankind has had to face during its history. Indeed, humans have recurrently been threatened by several emerging pathogens that killed a substantial fraction of the population. 
  • 1.1K
  • 19 Apr 2022
Topic Review
Canine Leishmaniasis
During canine leishmaniasis (CanL) due to Leishmania infantum (L. infantum), uncontrolled infection leads to a strong humoral immune response. As a consequence of the production of high antibody levels and the prolonged presence of parasite antigens, circulating immune complexes (CIC) are formed, which can be deposited in certain organs and tissues, inducing vasculitis, uveitis, dermatitis and especially glomerulonephritis and renal failure. A method to detect CIC, and quantify their levels in serum samples from dogs infected with L. infantum has been recently described. It allowed to demonstrate a correlation between CIC levels and disease severity. Thus, CIC measurement may be useful for diagnosis, assessment of disease progression and for monitoring response to treatment. This is an interesting finding, considering that there remains an urgent need for identification of novel biomarkers to achieve a correct diagnosis and for optimal disease staging of dogs suffering from Leishmania infection.
  • 1.1K
  • 24 May 2021
Topic Review
Robert Koch
Robert Heinrich Hermann Koch was a pioneering German physician and microbiologist whose groundbreaking work laid the foundations for modern bacteriology. He is most renowned for discovering the causative agents of tuberculosis, cholera, and anthrax, and for formulating the postulates that define pathogenic organisms in infectious diseases.
  • 1.1K
  • 14 Jul 2025
Topic Review
Hydatid Cyst Chemotherapy by Nanotechnology
Hydatid cysts have been widely recognized for decades as a common medical problem that affects millions of people. A revolution in medical treatment may be on the prospect of nanotechnology enhancing chemotherapy against hydatid cysts.
  • 1.1K
  • 17 Nov 2023
Topic Review
Adrenomedullin and COVID-19
The COVID-19 pandemic is still in progress, and a significant number of patients have presented with severe illness. Recently introduced vaccines, antiviral medicines, and antibody formulations can suppress COVID-19 symptoms and decrease the number of patients exhibiting severe disease. However, complete avoidance of severe COVID-19 has not been achieved and there are insufficient methods to treat it. Adrenomedullin (AM) is an endogenous peptide that maintains vascular tone and endothelial barrier function. The AM plasma level is markedly increased during severe inflammatory disorders, such as sepsis, pneumonia, and COVID-19, and associated with its prognosis. Exogenous AM administration reduced inflammation and related organ damage in rodent models. The results strongly suggest that AM could be an alternative therapy for COVID-19. Researchers are currently conducting an investigator-initiated phase 2a trial for moderate to severe COVID-19 using AM.
  • 1.1K
  • 07 Mar 2022
Topic Review
Artificial Intelligence in Combating Antimicrobial Resistance
Artificial intelligence (AI) is a branch of science and engineering that focuses on the computational understanding of intelligent behavior. Many human professions, including clinical diagnosis and prognosis, are greatly useful from AI. The rising incidence of antimicrobial resistance has become a significant issue, and authorities must take measures to combat the overuse and incorrect use of antibiotics in order to combat rising resistance rates. When it comes to infectious diseases, AI has the potential to be a game-changer in the battle against antibiotic resistance. 
  • 1.1K
  • 30 Jun 2022
Topic Review
Monoclonal Antibodies in COVID-19 Treatment
Therapeutic monoclonal antibodies (mAbs) have been the subject of widespread investigation focusing on two target-based groups, i.e., non-SARS-CoV-2 specific mAbs, that target immune system responses, and SARS-CoV-2 specific mAbs, designed to neutralize the virus protein structure.
  • 1.1K
  • 23 Jun 2021
Topic Review
Antifungal Drug Resistance
Fungal infections, named mycosis, can cause severe invasive and systemic diseases that can even lead to death. In recent years, epidemiological data have recorded an increase in cases of severe fungal infections, caused mainly by a growing number of immunocompromised patients and the emergence of fungal pathogenic forms that are increasingly resistant to antimycotic drug treatments.
  • 1.1K
  • 13 Apr 2023
Topic Review
Blood Stream Infections
Blood Stream Infections (BSIs) are defined by positive blood culture or cultures (with an isolate of the same species grown in at least one blood culture bottle) in a patient with systemic signs of infection (i.e., a patient who has evidence of one or more of the symptoms or signs, which are fever (body temperature > 38 °C), hypothermia (body temperature < 36 °C), chills, hypotension, oliguria, or high lactate levels).
  • 1.1K
  • 23 Nov 2021
Topic Review
Nanotechnology in Viral Respiratory Infections
Viral-associated respiratory infectious diseases are one of the most prominent subsets of respiratory failures, known as viral respiratory infections (VRI). VRIs are proceeded by an infection caused by viruses infecting the respiratory system. Due to their specific physical and biological properties, nanoparticles hold promising opportunities for both anti-viral treatments and vaccines against viral infections.
  • 1.1K
  • 05 Aug 2021
  • Page
  • of
  • 32
Featured Entry Collections
>>

Featured Reprints

>>
Encyclopedia of Digital Society, Industry 5.0 and Smart City
Encyclopedia of Engineering
Encyclopedia of Social Sciences
Encyclopedia of Medieval Royal Iconography
Academic Video Service
Feedback

Quick Survey

Encyclopedia MDPI is conducting a targeted survey to identify the specific barriers hindering efficient research. We invite you to spend 3 minutes defining the priorities for our next generation of structured knowledge tools.
Take Survey